Chris Jacob

The official Aston Martin Aramco Formula One® Team LinkedIn account. #IAM

Glaucoma is the leading cause of blindness and is often related to high intraocular pressure. However, over 10% have progressive visual loss despite optimal intraocular pressure lowering. Our drugs are proven to reduce visual loss in animal studies. Non-human primate studies are pending, and human trials will begin in 2025. Diabetic Retinopathy (DR) is caused by damage to blood vessels in the retina of diabetic patients leading to vision loss. Our DR therapeutics are in the early stages of pre-clinical studies

Gaingels is a leading venture investment syndicate in support of and representing the LGBTQIA+ community and allies in the venture capital space. Gaingels also supports its companies with a diverse talent and capital pipeline and provides an internal diverse board member recruitment advisory to help bring more diversity and representation within private boards. Gaingels invests in companies with diverse/LGBTQIA+ founders and C-suite leaders at all stages of growth, as well as in other high-growth companies resolved on building more inclusive teams. Gaingels is an ardent supporter the Diversity Term Sheet Rider Initiative to increase access to venture funding events for non-traditional check writers, and regularly co-invests with select VC leads across a variety of sectors, from technology, to B2B, healthcare and consumer, in competitive and over-subscribed rounds from Seed to Growth/pre-IPO. For more information visit www.gaingels.com.

The official Aston Martin Aramco Formula One® Team LinkedIn account. #IAM

Glaucoma is the leading cause of blindness and is often related to high intraocular pressure. However, over 10% have progressive visual loss despite optimal intraocular pressure lowering. Our drugs are proven to reduce visual loss in animal studies. Non-human primate studies are pending, and human trials will begin in 2025. Diabetic Retinopathy (DR) is caused by damage to blood vessels in the retina of diabetic patients leading to vision loss. Our DR therapeutics are in the early stages of pre-clinical studies

The Band of Angels is Silicon Valleys oldest seed funding organization. We are a formal group of more than 150 former and current high tech executives who are interested in investing their time and money into new, cutting edge, startup companies. Weve seeded over 277 companies in our history with 61 profitable M&A exits and 11 IPOs. Band members have founded companies such as Symantec, Logitech, and National Semiconductor and been senior executives at the likes of Sun Microsystems, Hewlett Packard, and Intuit. The Band meets monthly to formally consider three startups selected from among the more than 50 that are screened each month by the Band Deal Selection Process. Entrepreneurs can expect a thorough examination and, occasionally, an investment from some of Silicon Valleys most accomplished entrepreneurs.

Life Science Angels (LSA) is the premier angel investing organization in the US, focused on investing exclusively in the life sciences. Since 2005, LSA has invested in 100+ companies in medical technology and biotechnology investment opportunities.

March of Dimes leads the fight for the health of all moms and babies. We’re advocating for policies to protect them. We’re working to radically improve the health care they receive. We’re pioneering research to find solutions. We’re empowering families with programs, knowledge and tools to have healthier pregnancies. By uniting communities, we’re building a brighter future for us all.